Assessment of the effect of using intrauterine platelet-rich-plasma on the success of assisted reproduction: a systematic review and meta-analysis of randomized controlled trials
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20242995Keywords:
PRP, ART, Clinical pregnancy rates, Live birth rates, Meta-analysisAbstract
Intrauterine administration of platelet-rich-plasma (PRP) has shown potential in improving pregnancy outcomes in assisted reproductive technology (ART). However, the efficacy of PRP in enhancing clinical pregnancy and live birth rates remains a topic of debate. This meta-analysis evaluated the effectiveness of intrauterine PRP administration in improving clinical pregnancy and live birth rates. A systematic search of electronic databases was conducted to identify randomized controlled trials (RCTs) comparing intrauterine PRP administration with control in women undergoing ART. The primary outcomes were clinical pregnancy rates and live birth rates. Data were extracted and pooled using a random-effects model to calculate odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity was assessed using the I² statistic. Nineteen RCTs involving 1,918 participants were included for clinical pregnancy rates, and six RCTs involving 777 participants were included for live birth rates. The pooled OR for clinical pregnancy rates was 2.49 (95% CI: 1.84, 3.35), indicating a significant improvement in the PRP group. For live birth rates, the pooled OR was 3.28 (95% CI: 1.18, 9.09), also favouring the PRP group. Moderate heterogeneity was observed for clinical pregnancy rates (I²=43%), while substantial heterogeneity was observed for live birth rates (I²=77%). Funnel plots showed no significant publication bias for either outcome. Intrauterine PRP administration significantly improves clinical pregnancy and live birth rates in women undergoing ART. The pooled ORs of 2.49 for clinical pregnancy rates and 3.28 for live birth rates support the potential clinical utility of PRP in enhancing ART outcomes.
Metrics
References
Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018;62:2-10.
La Marca A, Mastellari E. Infertility: Epidemiology and etiology. In: Female Reproductive Dysfunction. 2020;211-33.
Farquhar C, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2018;8:CD013145.
Chambers GM, Dyer S, Zegers-Hochschild F, de Mouzon J, Ishihara O, Banker M, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014. Hum Reprod. 2021;36(11):2921-34.
Peter I, Wu K, Diaz R, Borg-Stein J. Platelet-rich plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825-53.
Farimani M, Bahmanzadeh M, Poorolaja J. A new approach using autologous platelet-rich plasma to treat infertility and to improve population replacement rate. J Res Health Sci. 2016;16(3):172.
Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35(5):753-6.
Sfakianoudis K, Simopoulou M, Nitsos N, Lazaros L, Rapani A, Pantou A, et al. Successful implantation and live birth following autologous platelet-rich plasma treatment for a patient with recurrent implantation failure and chronic endometritis. In Vivo. 2019;33(2):515-21.
Kusumi M, Ihana T, Kurosawa T, Ohashi Y, Tsutsumi O. Intrauterine administration of platelet‐rich plasma improves embryo implantation by increasing the endometrial thickness in women with repeated implantation failure: a single‐arm self‐controlled trial. Reprod Med Biol. 2020;19(4):350-6.
Mouanness M, Ali-Bynom S, Jackman J, Seckin S, Merhi Z. Use of intra-uterine injection of platelet-rich plasma (PRP) for endometrial receptivity and thickness: a literature review of the mechanisms of action. Reprod Sci. 2021;28(6):1659-70.
Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, Liang X. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015;8(1):1286.
Nazari L, Salehpour S, Hoseini S, Zadehmodarres S, Ajori L. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. Int J Reprod Biomed. 2016;14(10):625.
Tandulwadkar SR, Naralkar MV, Surana AD, Selvakarthick M, Kharat AH. Autologous intrauterine platelet-rich plasma instillation for suboptimal endometrium in frozen embryo transfer cycles: a pilot study. J Hum Reprod Sci. 2017;10(3):208-12.
Pantos K, Simopoulou M, Pantou A, Rapani A, Tsioulou P, Nitsos N, et al. A case series on natural conceptions resulting in ongoing pregnancies in menopausal and prematurely menopausal women following platelet-rich plasma treatment. Cell Transplant. 2019;28(9-10):1333-40.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Abduljabbar HS, Hashim H, Abduljabar HH, Elnaeim AA, Abduljabar NH. The effect of autologous platelet-rich plasma treatment on in vitro fertilization/intracytoplasmic sperm injection and its impact on the endometrium and clinical pregnancy rate. Cureus. 2022;14(8):e27913.
Allahveisi A, Seyedoshohadaei F, Rezaei M, Bazrafshan N, Rahimi K. The effect of platelet-rich plasma on the achievement of pregnancy during frozen embryo transfer in women with a history of failed implantation. Heliyon. 2020;6(3):e03577.
Bakhsh AS, Maleki N, Sadeghi MR, SadeghiTabar A, Tavakoli M, Zafardoust S, Karimi A, Askari S, Jouhari S, Mohammadzadeh A. Effects of autologous platelet-rich plasma in women with repeated implantation failure undergoing assisted reproduction. JBRA Assist Reprod. 2022;26(1):84.
Baybordi E, Mohseni J, Mosapour P. The effect of platelet-rich plasma on the improvement of pregnancy results in repeated implantation failure: a randomized controlled trial. Int J Reprod Biomed. 2022;20(9):753-60.
Dawood AS. Intrauterine infusion of autologous platelet-rich plasma before frozen embryo transfer in patients with prior implantation failure: a randomized controlled study. Egypt J Fertil Steril. 2022;26(1):12-22.
Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwanese J Obstet Gynecol. 2021;60(5):973.
El-Samman AA, Wafa YA, Al-Omda FA, Ali MA. Autologous intrauterine platelet rich plasma instillation in repeated implantation failure in assisted reproductive techniques. Al-Azhar Int Med J. 2022;3(2):100-6.
Ershadi S, Noori N, Dashipoor A, Ghasemi M, Shamsa N. Evaluation of the effect of intrauterine injection of platelet-rich plasma on the pregnancy rate of patients with a history of implantation failure in the in vitro fertilization cycle. J Family Med Prim Care. 2022;11(5):2162-6.
Nazari LS, Hoseini S, Zadehmodarres S, Azargashb E. Effects of autologous platelet-rich plasma on endometrial expansion in patients undergoing frozen-thawed embryo transfer: a double-blind RCT. Int J Reprod Biomed. 2019;17(6):445-50.
Nazari LS, Hosseini MS, Hashemi Moghanjoughi P. The effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial. Hum Fertil (Cambridge). 2020;23(3):209-13.
Nazari L, Salehpour S, Hosseini S, Sheibani S, Hosseinirad H. The effects of autologous platelet-rich plasma on pregnancy outcomes in repeated implantation failure patients undergoing frozen embryo transfer: a randomized controlled trial. Reprod Sci. 2021;29(3):993-1000.
Nazari LS, Hosseini S, Hashemi T, Borumandnia N, Azizi E. Effect of autologous platelet-rich plasma for treatment of recurrent pregnancy loss: a randomized controlled trial. Obstet Gynecol Sci. 2022;65(3):266-72.
Obidniak D, Gzgzyan A, Feoktistov A, Niauri D. Randomized controlled trial evaluating efficacy of autologous platelet-rich plasma therapy for patients with recurrent implantation failure. Fertil Steril. 2017;108(3):e370.
Pourkaveh B, Pakravesh J, Shabani M, Gachkar L, Nazarian H, Ghaffari Novin M, et al. Intrauterine platelet rich plasma (PRP) infusion could change the leukemia inhibitory factor (LIF) pattern in the endometrial secretion of women with recurrent implantation failure: a randomized clinical trial. Int J Med Toxicol Forensic Med. 2022:38493.
Rageh K. PRP in recurrent implantation failure: hope or hype? Arab Gulf Sci Res. 2020;38:24.
Safdarian LA, Aghahoseini M, Lak P, Mosa SH, Sarvi F, Mahdavi A, et al. Efficacy of the intrauterine infusion of platelet-rich plasma on pregnancy outcomes in patients with repeated implantation failure: a randomized control trial. Int J Womens Health. 2022;10(1):38-44.
Tehraninejad ES, Kashani NG, Hosseini A, Tarafdari A. Autologous platelet-rich plasma infusion does not improve pregnancy outcomes in frozen embryo transfer cycles in women with history of repeated implantation failure without thin endometrium. J Obstet Gynaecol Res. 2021;47(1):147-51.
Zamaniyan MPS, Heidaryan Gorji H, Moradi S, Jamal J, Yahya Poor Aghmashhadi J, Hossein Mohammadi M. Effect of platelet-rich plasma on pregnancy outcomes in infertile women with recurrent implantation failure: a randomized controlled trial. Gynecol Endocrinol. 2021;37(2):141-5.
Zargar MPR, Najafian M, Choghakabodi PM. Effects of intrauterine autologous platelet-rich plasma infusions on outcomes in women with repetitive in vitro fertilization failures: a prospective randomized study. Clin Exp Obstet Gynecol. 2021;48(1):180-5.
Bos-Mikich A, Ferreira MO, De Oliveira R, Frantz N. Platelet-rich plasma or blood-derived products to improve endometrial receptivity? J Assist Reprod Genet. 2019;36(4):613-20.
Mouanness M, Ali-Bynom S, Jackman J, Seckin S, Merhi Z. Use of intra-uterine injection of platelet-rich plasma (PRP) for endometrial receptivity and thickness: a literature review of the mechanisms of action. Reprod Sci. 2021;28(6):1659-70.
Downloads
Published
How to Cite
Issue
Section
